INTRODUCTION: Neonatal Abstinence Syndrome (NAS) is a condition unique to a newborn that results from the abrupt cessation of chronic intrauterine drug exposure following birth. Slightly persistent, late onsetting, or slowly fading-out symptoms’ manifestation may take weeks or months. In case the infant is not kept in the biological family, one possible subsequent placement after discharge from hospital in the Czech Republic is a Temporary Foster Care Institution called Pěstounská péče na přechodnou dobu (TFCI). It is unclear what knowledge, education, and experience TFCI caregivers have in...

This webinar explored the issues of infants withdrawing from maternal drugs of addiction, and problems beyond the newborn period.

Newborn drug withdrawal is often attributed to maternal opioids, but many other drugs can cause serious problems in the newborn infant. The impact of prenatal substance exposure extends beyond the newborn period and may have serious long-term consequences on the infant until adulthood.

Early identification, intervention and awareness of the potential problems caused by maternal drug exposure is vital to minimise the harm of prenatal drug exposure on infants.

Résumé

Introduction : la consommation d’alcool pendant la grossesse (CADE) produit des problèmes physiques, cognitifs et comportementaux chez la mère et chez le bébé à naître, c’est pourquoi l’abstinence de cette substance pendant la grossesse est recommandée ; Cependant, les facteurs présents chez les adolescents peuvent être liés à l’initiation ou à la poursuite de la consommation d’alcool pendant la grossesse.

Objectif : Identifier la prévalence et les facteurs liés à la consommation d’alcool chez les adolescentes enceintes (EI) par le biais d’une revue systématique.

Méthode : Recherche...

The focus of this seminar is on prescription smoking cessation pharmacotherapies, which include nicotine replacement therapy patches, varenicline and bupropion.

Dr Alys Havard presents data on the number of Australian women who use these medicines during pregnancy, and their findings regarding the risk of adverse birth outcomes associated with the use of each of these medicines during pregnancy.

She will also show how nicotine replacement therapy patches and varenicline compare in terms of effectiveness when used during pregnancy. We addressed these research questions using linked routinely...

Summary

What is already known about this topic?

Most electronic vapor products (EVPs) contain nicotine, a developmental toxicant, and other harmful additives.

What is added by this report?

In 2015, 7.0% of women with a recent live birth in Oklahoma and Texas reported using EVPs shortly before, during, or after pregnancy, with 1.4% reporting use during pregnancy. Among prenatal EVP users, 38.4% reported using EVPs containing nicotine, and 26.4% did not know if the EVPs they used contained nicotine.

What are the implications for public health practice?

Messages that EVPs are not safe to...

Summary

What is already known about this topic?

In 2014, in the United States, an infant with neonatal abstinence syndrome (NAS) was born every 15 minutes. Historically, NAS surveillance has depended on hospital discharge data, frequently with a time lag, limiting ability to rapidly direct public health resources.

What is added by this report?

Among six identified states with mandated NAS reporting laws during 2013–2017, NAS incidence could be quantified to inform programs and services. However, differences in reporting methods and case definitions might influence states’ abilities to...